AuditLine › HHS OIG › Food and Drug Administration
HHS OIG recommendation 22-E-01-034.04
FDA should expand and improve resources for test developers on the Emergency Use Authorization (EUA) process.
The recommendation, in the publisher's words
FDA should expand and improve resources for test developers on the Emergency Use Authorization (EUA) process.
- Responsible agency
- Food and Drug Administration
- Issued
- September 16, 2022
- Report
- FDA Repeatedly Adapted Emergency Use Authorization Policies To Address the Need for COVID-19 Testing (OEI-01-20-00380) · find it at HHS OIG
- Kind of report
- Evaluation
- Agency response
- Concur (as recorded by the publisher)
- Closed
- April 7, 2025 (publisher's date)
- Publisher topics
- COVID-19, Departmental Operational Issues, Emergency Preparedness and Response, Food; Drug and Device Safety, Laboratories, Medical Supplies and Equipment, Prescription Drug, Public Health Issues
“Open” and “closed” are the publisher's words. AuditLine repeats them with the date it read them. It does not check whether a recommendation was carried out, and a closed recommendation is not proof that a problem was fixed.
Dated history
- Issued by HHS OIG. (publisher's date)
- Closed, with status “Closed Implemented”. (publisher's date)
- First recorded by AuditLine. (start of AuditLine's own history for this record)
Dates marked "publisher's date" come from the publisher's file. AuditLine's own observations begin November 10, 2026 and are added each time the publisher's file changes.
Other recommendations from this report
5 more, of which 0 are open in the publisher's file.
- FDA should assess and, as appropriate, revise FDA guidance for test Emergency Use Authorization (EUA) submissions.HHS OIG 22-E-01-034.01 · issued Sep 16, 2022 · closed Mar 30, 2026Closed Implemented
- FDA should develop a suite of Emergency Use Authorization (EUA) templates for future emergencies involving novel pathogens.HHS OIG 22-E-01-034.02 · issued Sep 16, 2022 · closed Sep 29, 2025Closed Unimplemented
- FDA should expand the Center for Devices and Radiological Health's existing device-tracking platform to facilitate Emergency Use Authorization (EUA) submission and monitoring.HHS OIG 22-E-01-034.03 · issued Sep 16, 2022 · closed Sep 29, 2025Closed Unimplemented
- FDA should establish formal communication channels between FDA and the lab community, to be used in emergencies that require testing.HHS OIG 22-E-01-034.05 · issued Sep 16, 2022 · closed Apr 2, 2024Closed Implemented
- FDA should work with Federal partners to implement lessons learned about a national testing strategy outside the Emergency Use Authorization (EUA) process.HHS OIG 22-E-01-034.06 · issued Sep 16, 2022 · closed Mar 30, 2026Closed Implemented
Source
Open this report in HHS OIG's tracker This publisher's records (CSV)
Official export: https://oig.hhs.gov/recommendations/export-recs/. File read , 4,677 rows,
SHA-256 664fdfb3658ecb72…. HHS OIG's status, response, dates and potential-savings labels are the publisher's own claims.